Details for New Drug Application (NDA): 206516
✉ Email this page to a colleague
The generic ingredient in LEVOLEUCOVORIN CALCIUM is levoleucovorin calcium. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the levoleucovorin calcium profile page.
Summary for 206516
Tradename: | LEVOLEUCOVORIN CALCIUM |
Applicant: | Actavis Llc |
Ingredient: | levoleucovorin calcium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 206516
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 50MG BASE/VIAL | ||||
Approval Date: | Feb 13, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription